Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

BCG Therapy for Bladder Cancer Guide

BCG (Bacillus Calmette-Guérin) is a live vaccine against tuberculosis. It’s also key in BCG Therapy for Bladder Cancer. At Liv Hospital, we focus on both treatment success and patient comfort.

By putting the BCG vaccine in the bladder, we help the immune system fight cancer. This method has shown great promise. But, it’s important for patients to know about possible side effects of BCG Therapy for Bladder Cancer.

We’re a top healthcare provider, dedicated to patient care. We use new ways to improve treatment results. Our aim is to give world-class care and support to international patients.

BCG Therapy for Bladder Cancer
BCG Therapy for Bladder Cancer: Safe Guide 5

Key Takeaways

  • BCG Therapy for Bladder Cancer is a widely used immunotherapy for non-muscle invasive bladder cancer.
  • The treatment involves introducing the BCG vaccine directly into the bladder.
  • Patients should be aware of the possible side effects of BCG Therapy for Bladder Cancer.
  • Liv Hospital puts patients first and uses new healthcare solutions.
  • We aim to find the right balance between treatment success and patient comfort.

Understanding BCG Therapy for Bladder Cancer

BCG Therapy for Bladder Cancer is a key treatment option. It uses a tuberculosis vaccine to fight cancer cells. This method is a mainstay for non-muscle invasive bladder cancer.

What is BCG Therapy?

BCG, or Bacillus Calmette-Guérin, is a vaccine made from a germ related to tuberculosis. It’s put into the bladder to boost the immune system against bladder cancer cells. BCG Therapy for Bladder Cancer is not for treating tuberculosis but to fight cancer with the immune system.

BCG Therapy for Bladder Cancer
BCG Therapy for Bladder Cancer: Safe Guide 6

Doctors say, “The BCG vaccine is used for its immunotherapeutic properties in treating bladder cancer.” This shows how versatile and promising BCG Therapy for Bladder Cancer is.

How BCG Works Against Bladder Cancer ?

BCG Therapy for Bladder Cancer induces a strong immune response against bladder cancer cells. When administered, it sparks an immune reaction that kills cancer cells. The process involves activating immune cells like macrophages and T-cells.

  • Stimulates immune response
  • Activates immune cells like macrophages and T-cells
  • Helps in destroying bladder cancer cells

Understanding BCG Therapy for Bladder Cancer helps patients and doctors see the value of immunotherapy.

The Science Behind BCG Immunotherapy

BCG immunotherapy is a key treatment for bladder cancer. It uses a form of immunotherapy called BCG, or Bacillus Calmette-Guérin. This method is effective for treating non-muscle invasive bladder cancer (NMIBC).

Mechanism of Action

BCG immunotherapy works by boosting the body’s immune system to fight cancer cells. When BCG is put into the bladder, it causes a local infection. This infection triggers an immune response.

This response includes the activation of natural killer cells, macrophages, and T lymphocytes. These immune cells work together to destroy cancer cells.

The process starts with BCG sticking to the bladder wall. Then, immune cells take it in. This leads to the making of cytokines and chemokines. These molecules help coordinate the immune response.

The immune response from BCG therapy involves immune cells moving into the bladder wall. There, they target and kill cancer cells.

Immune System Response

The immune system’s response to BCG immunotherapy is complex. It involves many parts of the immune system. The therapy triggers a Th1-type immune response. This type of response is key for fighting tumors.

Research shows that BCG immunotherapy’s success depends on a strong immune response against the tumor. The presence of immune cells in the tumor microenvironment affects the therapy’s outcome.

Who is a Candidate for BCG Therapy for Bladder Cancer?

BCG treatment is for patients with a certain type of bladder cancer. This cancer hasn’t invaded the muscle wall. We’ll look at who fits this criteria.

Non-Muscle Invasive Bladder Cancer (NMIBC)

Non-muscle invasive bladder cancer is when tumors stay in the bladder’s lining. They haven’t grown into the main muscle layer. BCG is mainly used for this stage of bladder cancer. NMIBC is divided based on how likely it is to come back or grow.

The success of BCG Therapy for Bladder Cancer depends on NMIBC’s characteristics. We look at tumor size, grade, and if there are many tumors.

Risk Stratification and Patient Selection

Risk stratification helps figure out who will benefit most from BCG treatment. It involves checking several things, like:

  • Tumor stage and grade
  • Presence of carcinoma in situ
  • History of previous treatments
  • The patient’s overall health and immune status

Healthcare professionals use these factors to find the best candidates for BCG therapy. This way, they can help patients while keeping risks low.

In short, BCG Therapy for Bladder Cancer is a good choice for patients with non-muscle invasive bladder cancer. Knowing who’s a good candidate and how to assess risks helps make this therapy more effective.

The BCG Therapy for Bladder Cancer Process

Understanding the process is key for patients. It involves several steps to put the BCG vaccine in the bladder. This helps fight cancer cells by boosting the immune system.

Pre-Treatment Preparation

Before starting BCG treatment, patients go through some steps. They might have a cystoscopy to check the bladder. This makes sure there are no tumors or debris that could get in the way.
They also tell their doctor about any medicines they’re taking. And about any urinary tract infections or other health problems.

Administration Procedure

The BCG vaccine is put into the bladder through a catheter. This happens in a doctor’s office or clinic. The vaccine stays in the bladder for about two hours before being flushed out.
During this time, patients move every 15 minutes. This helps the vaccine cover the whole bladder wall.

Standard Treatment Schedule

The usual BCG treatment schedule is once a week for six weeks. This first part is important for getting the immune system ready to fight cancer. After that, more treatments might be needed, spaced out at regular times.

Treatment PhaseFrequencyDuration
Induction CourseOnce weekly6 weeks
Maintenance TherapyOnce every 3-6 monthsUp to 3 years

It’s very important for patients to stick to the treatment schedule. Regular check-ups with doctors are also key. They help make sure the treatment is working and deal with any side effects quickly.

Side Effect #1: Urinary Frequency and Urgency

Many people experience urinary frequency and urgency when they undergo BCG Therapy for Bladder Cancer. These symptoms can be uncomfortable and disrupt daily life. But, knowing why they happen and how to manage them can make treatment easier.

Why It Happens ?

BCG treatment boosts the immune system to fight bladder cancer. This boost can cause inflammation in the bladder. This irritation makes patients feel the need to urinate more often and with greater urgency.

Management Strategies

Managing urinary frequency and urgency requires lifestyle changes and sometimes medication. Here are some strategies to help:

  • Fluid Management: Drinking less fluid, mainly in the evening, can cut down on nighttime trips to the bathroom.
  • Bladder Training: Increasing the time between bathroom visits can help the bladder hold more.
  • Dietary Changes: Staying away from caffeine, alcohol, and spicy foods can lessen symptoms.
  • Medications: Sometimes, doctors prescribe drugs to relax the bladder muscle.
Management StrategyDescriptionBenefit
Fluid ManagementLimiting fluid intake, mainly before bedtimeReduces nighttime urination
Bladder TrainingGradually increasing time between urinationsImproves bladder capacity
Dietary ChangesAvoiding irritants like caffeine and spicy foodsReduces symptom severity

Expected Duration

The time these symptoms last can vary. They are usually most severe during and right after BCG treatment. For many, symptoms start to get better a few weeks after treatment ends. But, for some, it may take months for symptoms to fully go away.

Talking to your healthcare provider about these symptoms is key. They can offer personalized advice and care. Understanding what to expect and how to manage side effects can help patients get through BCG Therapy for Bladder Cancer more smoothly.

Side Effect #2: Dysuria (Painful Urination)

Dysuria, or painful urination, is a common side effect of BCG Therapy for Bladder Cancer. It can feel like a mild burning or severe pain when you pee.

BCG Therapy for Bladder Cancer
BCG Therapy for Bladder Cancer: Safe Guide 7

Causes and Symptoms

The body’s immune response to BCG therapy causes dysuria. Symptoms include:

  • Pain or burning during urination
  • Stinging sensation in the urethra
  • Discomfort in the bladder or pelvic area

Relief Measures

Here are some ways to ease dysuria:

  • Hydration: Drink lots of water to make your urine less irritating.
  • Urinary Alkalizers: Use over-the-counter meds to make your urine less acidic.
  • Pain Management: Take pain meds as your doctor suggests.

Distinguishing from Infection

It’s important to tell the difference between BCG treatment side effects and a UTI. Both can cause painful pee, but UTIs also bring:

  • Fever
  • Cloudy or strong-smelling urine
  • Frequent need to pee

If you have these extra symptoms, see your doctor right away.

Side Effect #3: Hematuria (Blood in Urine)

Hematuria, or blood in the urine, is a common side effect of BCG Therapy for Bladder Cancer. It can be scary for patients. But knowing what it means and how to handle it is key for those going through this treatment.

Understanding the Severity Spectrum

Hematuria can be either microscopic (only seen under a microscope) or gross (visible to the eye). Gross hematuria is more alarming. The severity can differ from person to person and may change during treatment.
We categorize hematuria’s severity to understand its impact:

Severity LevelDescriptionTypical Action
MicroscopicBlood visible only under a microscopeMonitoring, possibly no immediate action
GrossBlood visible to the naked eyeNotify doctor, possible adjustment in treatment
SevereSignificant bleeding, potentially causing clotsImmediate medical attention required

When to Contact Your Doctor ?

It’s important for patients to know when to talk to their doctor about hematuria. If you notice any of these signs, call your doctor:

  • Persistent or recurrent gross hematuria
  • Severe hematuria that causes clots or significant discomfort
  • Associated symptoms like pain or difficulty urinating

Treatment Options

The treatment for hematuria depends on its severity and your health. Sometimes, it goes away without treatment. But in severe cases, your doctor might suggest:

  • Drinking more water to flush out your bladder
  • Medicines to stop bleeding or ease symptoms
  • Changing or stopping BCG treatment

In summary, while hematuria is a concern with BCG Therapy for Bladder Cancer, knowing its severity and when to see a doctor can help manage it. We’re here to support you through your treatment.

Side Effect #4: Flu-Like Symptoms

BCG treatment is good against bladder cancer but can make patients feel flu-like. This is because the body is fighting off the BCG therapy.

Common Manifestations

BCG treatment can make patients feel like they have the flu. They might have fever, chills, tiredness, and pain in muscles or joints. This happens because the body is reacting to the BCG vaccine.

Duration and Management

Flu-like symptoms usually last 2 to 3 days after each BCG treatment. It’s important to manage these symptoms well to keep patients comfortable during treatment.

To help with these symptoms, patients should:

  • Drink lots of fluids to stay hydrated.
  • Get plenty of rest to help the body heal.
  • Take over-the-counter medicines like acetaminophen or ibuprofen, but only if their doctor says it’s okay.

Medication Considerations

It’s very important to talk to a doctor before taking any medicine for flu-like symptoms. Some medicines might not work well with BCG treatment or could cause problems.
Here’s a quick guide on how to manage symptoms:

SymptomManagement Strategy
FeverUse acetaminophen or ibuprofen as directed.
FatigueRest and eat a balanced diet.
Muscle/Joint PainTry physical therapy or gentle exercises.

By understanding and managing flu-like symptoms, patients can handle BCG Therapy for Bladder Cancer side effects better. This way, they can keep up with their treatment plan.

Side Effect #5: Bladder Contracture and Reduced Capacity

BCG therapy can cause bladder contracture and reduced bladder capacity. It treats bladder cancer but can lead to chronic inflammation and scarring. This scarring can reduce the bladder’s capacity and cause contracture over time.

Long-Term Considerations

Patients on BCG treatment face a risk of bladder contracture. This condition scars the bladder, reducing its size. Symptoms include frequent urination, urgency, and, in severe cases, incontinence.
Monitoring and follow-up are key to managing bladder contracture. Regular visits to healthcare providers help in early detection and treatment.

Preventive Measures

Preventive steps can help reduce the risk of bladder contracture. These include:

  • Regular monitoring of bladder function
  • Adjustments to the BCG treatment schedule if necessary
  • Management of symptoms as they arise
  • Lifestyle modifications to reduce bladder irritation

By being proactive, patients can lower their risk of severe bladder contracture.

Treatment Approaches

Treatment for bladder contracture depends on its severity. For mild cases, conservative management like bladder training and pelvic floor exercises may be enough.
For severe cases, surgical intervention might be needed. This could include procedures to increase bladder capacity or repair scarring.

It’s vital for patients to work with their healthcare team to find the best treatment for their situation.

Side Effect #6: Systemic BCG Infection

Systemic BCG infection is a rare but serious side effect of BCG immunotherapy. We will look into what this condition is, who is at risk, and how to respond.

BCG Therapy for Bladder Cancer
BCG Therapy for Bladder Cancer: Safe Guide 8

Recognizing Serious Complications

Systemic BCG infection happens when the BCG vaccine spreads to other parts of the body. Symptoms can vary widely but often include fever, chills, and feeling unwell. In severe cases, it can cause pneumonitis or hepatitis. It’s important to spot these symptoms early to manage them effectively.

Risk Factors

Some people are more likely to get systemic BCG infection. This includes those with weak immune systems, due to health issues or treatments. Research shows that choosing the right patients and watching them closely can help reduce this risk.

Emergency Response Protocol

If you think someone has systemic BCG infection, get them medical help right away. Treatment usually involves antibiotics, and sometimes, hospital care is needed for severe cases. It’s key to teach patients about the signs of this infection so they can get help quickly.

By knowing the risks and watching for signs of systemic BCG infection, we can give the best care to patients with bladder cancer getting BCG treatment.

Side Effect #7: Allergic Reactions

Allergic reactions can happen after BCG treatment. It’s important to watch for them. These reactions can be mild or severe and affect how well the treatment works.

Types of Allergic Responses

BCG treatment can cause different allergic reactions. Some common signs include:

  • Rash or itching
  • Swelling at the BCG site
  • Respiratory problems, like trouble breathing
  • In rare cases, anaphylaxis, a severe, life-threatening reaction

Patients should tell their doctor right away if they notice any unusual symptoms.

Monitoring and Treatment

Keeping an eye on allergic reactions is key. Doctors might:

  • Check patients for signs of allergic reactions during and after BCG treatment
  • Change treatment plans to lessen allergic reactions
  • Give medicines like antihistamines or corticosteroids to help symptoms

If a reaction is very severe, getting help right away is critical.

Symptom SeverityRecommended Action
MildWatch symptoms, think about antihistamines
ModerateGive corticosteroids, adjust BCG dose
SevereGet medical help fast, might need hospital

Prevention in Future Treatments

If you had an allergic reaction to BCG, there are ways to lower the risk of it happening again:

  • Take antihistamines or corticosteroids before BCG treatments
  • Change the BCG dose or how often you get it
  • Watch closely for early signs of allergic reactions

By working with your doctor, you can make your future treatments safer and less likely to cause severe allergic reactions.

Conclusion: Balancing Benefits and Side Effects

BCG Therapy for Bladder Cancer has changed how we treat non-muscle invasive bladder cancer. It greatly lowers the chance of cancer coming back or getting worse. At Liv Hospital, we know BCG treatment works well but can have side effects that need attention.

We’ve looked at the good things about BCG therapy and the side effects it can cause. These include frequent urination, painful urination, blood in the urine, flu-like symptoms, bladder tightness, BCG infection, and allergic reactions. It’s important to handle these side effects well to make sure the treatment works.

We focus on patient care and support in treating bladder cancer with BCG. By knowing the good and bad, patients can make better choices about their treatment. Liv Hospital aims to provide top-notch healthcare and support to patients worldwide, ensuring they get the best care.

Getting the side effects under control is essential for a good treatment outcome. By managing BCG therapy’s side effects carefully, patients can get the best results in fighting bladder cancer.

Frequently Asked Questions

What is BCG Therapy for Bladder Cancer?

BCG (Bacillus Calmette-Guérin) treatment is a type of immunotherapy for bladder cancer. It uses a weakened tuberculosis bacteria form in the bladder. This helps the immune system fight cancer cells.

How does BCG therapy work against bladder cancer?

BCG therapy boosts the immune system to attack bladder cancer cells. The weakened tuberculosis bacteria in BCG triggers an immune response. This response helps eliminate cancer cells in the bladder.

What are the common side effects of BCG Therapy for Bladder Cancer?

Side effects include urinary frequency and urgency, painful urination, and blood in urine. Patients may also experience flu-like symptoms, bladder contracture, and allergic reactions.

How can I manage urinary frequency and urgency after BCG treatment?

To manage these symptoms, limit fluid intake and avoid irritants like caffeine and spicy foods. Pelvic floor exercises can also help. Symptoms usually go away within a few days.

What is the risk of systemic BCG infection after treatment?

Systemic BCG infection is rare but serious. It can happen if the immune system is weak. Symptoms include fever, chills, and fatigue. Seek medical help if symptoms occur.

Can BCG treatment cause allergic reactions?

Yes, BCG can cause allergic reactions, from mild to severe. Symptoms include rash, itching, and difficulty breathing. It’s important to monitor and treat allergic reactions promptly.

How is BCG treatment administered?

BCG is given directly into the bladder through a catheter. It’s usually done once a week for several weeks. Maintenance treatments may follow as needed.

What is the standard treatment schedule for BCG therapy?

The standard schedule includes an initial phase of once-weekly treatments for six weeks. Maintenance treatments are given at regular intervals after that.

Are there any long-term side effects of BCG treatment?

Long-term side effects can include bladder contracture and reduced bladder capacity. Regular monitoring and follow-up care are key to managing these issues.

How can I minimize the risk of side effects from BCG treatment?

To reduce side effects, follow the recommended treatment schedule and report any symptoms or concerns. Regular follow-up appointments with your healthcare provider are also important.

What is the role of risk stratification in selecting patients for BCG treatment?

Risk stratification helps assess the risk of cancer recurrence and progression. It helps healthcare providers decide if BCG treatment is right for each patient.

Can tuberculosis medication be used to treat bladder cancer?

No, tuberculosis medication is not used to treat bladder cancer. But BCG, a weakened form of the tuberculosis bacteria, is used as an immunotherapy for non-muscle invasive bladder cancer.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91